• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BTG:LN

755.000 GBp 12.000 1.62%

As of 12:35:07 ET on 10/31/2014.

Snapshot for BTG PLC (BTG)

Open: 750.000 Day's Range: 748.000 - 755.500 Volume: 1,164,401
Previous Close: 743.000 52wk Range: 412.500 - 755.500 1-Yr Rtn: +79.93%

Stock Chart for BTG

No chart data available.
  • BTG:LN 755.000
  • 1D
  • 1M
  • 1Y
743.000
Interactive BTG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTG

Current P/E Ratio (ttm) 108.7802
Estimated P/E(03/2015) 49.3464
Relative P/E vs. UKX 6.5901
Earnings Per Share (GBP) (ttm) 0.0694
Est. EPS (GBP) (03/2015) 0.1530
Est. PEG Ratio -
Market Cap (M GBP) 2,739.34
Shares Outstanding (M) 362.83
30 Day Average Volume 816,248
Price/Book (mrq) 5.1470
Price/Sale (ttm) 9.2215
Dividend Indicated Gross Yield -%
Cash Dividend (GBp) -
Dividend Ex-Date 06/07/2000
5 Year Dividend Growth -
Next Earnings Announcement 11/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTG

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for BTG

BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.

Louise MakinCEO/Executive DirectorRolf SoderstromCFO/Executive Director
Peter StratfordCTO:Interventional MedicineGuenter R JanhoferChief Medical Officer/Head:Dev
More Company Profile & Key Executives for BTG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil